Rivastigmine | High-Quality Pharmaceutical Reference Standard
Rivastigmine is a cholinesterase inhibitor used in the treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease dementia. It works by inhibiting acetylcholinesterase and butyrylcholinesterase, increasing acetylcholine levels in the brain. Rivastigmine API is produced under GMP standards and is suitable for oral capsules, oral solution, and transdermal patch formulations.
Rivastigmine API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 11
